Free Trial

Passage Bio (PASG) SEC Filings & 10K Form

Passage Bio logo
$7.20 +0.07 (+0.91%)
Closing price 03:59 PM Eastern
Extended Trading
$7.20 0.00 (0.00%)
As of 04:27 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Passage Bio SEC Filings

DateFilerForm TypeView
08/12/2025
6:15 AM
Passage Bio (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/12/2025
6:00 AM
Passage Bio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/24/2025
4:44 PM
ORBIMED ADVISORS LLC (Filed by)
Passage Bio (Subject)
Form SCHEDULE 13D/A
07/24/2025
5:12 PM
Lynx1 Capital Management LP (Reporting)
Nichols Weston (Reporting)
Passage Bio (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/21/2025
4:28 PM
ORBIMED ADVISORS LLC (Filed by)
Passage Bio (Subject)
Form SCHEDULE 13D/A
07/21/2025
4:33 PM
ORBIMED ADVISORS LLC (Reporting)
Passage Bio (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/15/2025
7:17 PM
ORBIMED ADVISORS LLC (Reporting)
Passage Bio (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/14/2025
6:01 AM
Passage Bio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/09/2025
7:06 PM
ORBIMED ADVISORS LLC (Filed by)
Passage Bio (Subject)
Form SCHEDULE 13D/A
07/07/2025
5:02 PM
ORBIMED ADVISORS LLC (Reporting)
Passage Bio (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/26/2025
4:10 PM
ORBIMED ADVISORS LLC (Reporting)
OrbiMed Capital GP VII LLC (Reporting)
Passage Bio (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2025
5:48 PM
ORBIMED ADVISORS LLC (Reporting)
Passage Bio (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/23/2025
6:00 AM
Passage Bio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/30/2025
8:41 PM
Kapadia Sandip (Reporting)
Passage Bio (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/30/2025
6:26 PM
Kassberg Thomas Richard (Reporting)
Passage Bio (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/30/2025
6:27 PM
Passage Bio (Issuer)
Sondhi Dolan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/30/2025
6:28 PM
Islam Saqib (Reporting)
Passage Bio (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/30/2025
6:29 PM
Passage Bio (Issuer)
Porter Derrell (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/30/2025
6:30 PM
Countouriotis Athena (Reporting)
Passage Bio (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/30/2025
6:31 PM
GOWEN MAXINE (Reporting)
Passage Bio (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/13/2025
6:00 AM
Passage Bio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/13/2025
6:15 AM
Passage Bio (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/25/2025
6:48 PM
ORBIMED ADVISORS LLC (Filed by)
Passage Bio (Subject)
Form SCHEDULE 13D/A
04/24/2025
4:38 PM
ORBIMED ADVISORS LLC (Reporting)
OrbiMed Capital GP VII LLC (Reporting)
Passage Bio (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/17/2025
5:10 PM
ORBIMED ADVISORS LLC (Reporting)
OrbiMed Capital GP VII LLC (Reporting)
Passage Bio (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/16/2025
6:00 AM
Passage Bio (Filer)
Form DEF 14A
04/16/2025
6:01 AM
Passage Bio (Filer)
Form DEFA14A
04/16/2025
6:02 AM
Passage Bio (Filer)
Form ARS
04/15/2025
4:40 PM
ORBIMED ADVISORS LLC (Reporting)
Passage Bio (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/04/2025
6:15 AM
Passage Bio (Filer)
Form PRE 14A
03/18/2025
4:11 PM
Cale Edgar B. (Reporting)
Passage Bio (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2025
4:11 PM
Chou William (Reporting)
Passage Bio (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2025
4:12 PM
Borthwick Kathleen (Reporting)
Passage Bio (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2025
5:05 AM
Passage Bio (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/05/2025
5:09 AM
Passage Bio (Filer)
Form 424B5
03/04/2025
6:15 AM
Passage Bio (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/04/2025
6:00 AM
Passage Bio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2025
8:01 AM
Lynx1 Capital Management LP (Filed by)
Passage Bio (Subject)
Form SCHEDULE 13G/A
02/12/2025
3:21 PM
Borthwick Kathleen (Reporting)
Passage Bio (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/14/2025
4:17 PM
ORBIMED ADVISORS LLC (Reporting)
OrbiMed Capital GP VII LLC (Reporting)
Passage Bio (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/10/2025
6:00 AM
Passage Bio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/08/2025
5:09 PM
ORBIMED ADVISORS LLC (Reporting)
OrbiMed Capital GP VII LLC (Reporting)
Passage Bio (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/31/2024
3:05 PM
Lynx1 Capital Management LP (Reporting)
Nichols Weston (Reporting)
Passage Bio (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/26/2024
3:34 PM
ORBIMED ADVISORS LLC (Reporting)
OrbiMed Capital GP VII LLC (Reporting)
Passage Bio (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/26/2024
3:31 PM
ORBIMED ADVISORS LLC (Filed by)
Passage Bio (Subject)
Form SCHEDULE 13D/A
12/11/2024
4:32 PM
ORBIMED ADVISORS LLC (Reporting)
OrbiMed Capital GP VII LLC (Reporting)
Passage Bio (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/06/2024
6:07 PM
ORBIMED ADVISORS LLC (Reporting)
OrbiMed Capital GP VII LLC (Reporting)
Passage Bio (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/27/2024
5:11 PM
Lynx1 Capital Management LP (Reporting)
Nichols Weston (Reporting)
Passage Bio (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/14/2024
4:21 PM
Erste Asset Management GmbH (Filed by)
Passage Bio (Subject)
Form SCHEDULE 13G/A
11/13/2024
6:15 AM
Passage Bio (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/13/2024
6:00 AM
Passage Bio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/24/2024
6:00 AM
Passage Bio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/02/2024
3:41 PM
Cale Edgar B. (Reporting)
Passage Bio (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/23/2024
3:51 PM
ORBIMED ADVISORS LLC (Reporting)
OrbiMed Capital GP VII LLC (Reporting)
Passage Bio (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/18/2024
5:38 PM
ORBIMED ADVISORS LLC (Reporting)
OrbiMed Capital GP VII LLC (Reporting)
Passage Bio (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/16/2024
7:36 PM
ORBIMED ADVISORS LLC (Reporting)
Passage Bio (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/16/2024
7:38 PM
ORBIMED CAPITAL LLC (Reporting)
Passage Bio (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/16/2024
6:00 AM
Passage Bio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/10/2024
6:00 AM
Passage Bio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/06/2024
3:15 PM
Passage Bio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:PASG) was last updated on 9/4/2025 by MarketBeat.com Staff
From Our Partners